Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...

The following subsections of the Food and Drugs Act (FDA) set out the supplementary rules authority. Subsection 30.01(1), the authority to set out supplementary rules for a therapeutic product: ...

Pharmaceutical equivalent is defined in section C.08.001.1 of the FDR: means a new drug that, in comparison with another drug, contains identical amounts of the identical medicinal ingredients, in ...

BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The Pharmaceutical intermediates market is estimated to be valued at USD 47.30 Bn in 2025 and is expected to reach USD 82.70 Bn by ...

The United States pharmaceutical intermediates market is poised for steady growth, with projections indicating a rise from USD 6,591.4 million in 2025 to USD 9,052.8 million by 2035. This expansion ...

The China pharmaceutical intermediate market is set for significant expansion, with a projected valuation of USD 9,309.7 million in 2025, growing at a CAGR of 6.4% to reach USD 17,276.3 million by ...

The import of bulk drugs and drug intermediates to the country has seen a growth of 2.34 per cent in the first nine months of the current fiscal year, as compared to the same period of last year. The ...

Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% as a portion of active pharmaceutical ingredients (APIs) used in ...